Friday 6 November 2026
Export KRYS’s income statement to Excel — free account
Krystal Biotech, Inc.
KRYS Healthcare Biotechnology
Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024.
- Revenue
- +30.2%
- EPS
- −22.3%
- Free cash flow
- +137.8%
Quarter to September 2026, against a year earlier
300.31
0.06
+0.02%
Follow KRYS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | 6 | 5 |
| 18.91% | 19.90% | 20.12% | 17.50% | ||
| 17.14% | 18.21% | 18.30% | 15.93% | ||
ROIC |
25.73% | 24.64% | 24.07% | 27.15% | |
Return on Tangible Assets |
19.10% | 21.12% | 22.23% | 19.89% | |
Average Days of Receivables |
119.52 | 111.10 | 114.90 | 103.37 | |
Free Cash Flow per Share |
6.54 | 8.11 | 8.73 | 10.47 | |
Free Cash Flow |
189.35 | 237.38 | 257.78 | 310.08 | |
Capital Expenditures |
(11.52) | (12.89) | (14.56) | (13.85) | |
| Other line items | |||||
Cash ROIC |
9.25% | 11.30% | 11.69% | 13.21% | |
Accounts Receivable Turnover |
3.35 | 3.62 | 3.52 | 3.58 | |
Accounts Payable Turnover |
5.61 | 7.20 | 3.46 | 6.10 | |
Inventory Turnover |
0.69 | 0.67 | 0.62 | 0.61 | |
Average Days of Payables |
51.28 | 61.31 | 101.14 | 91.30 | |
Days of Inventory on Hand |
640.96 | 639.41 | 704.10 | 688.89 | |
Tax Rate |
0.08 | 0.09 | 0.07 | (0.13) | |
Research and Development Expense of Revenue |
14.92% | 14.17% | 13.45% | 12.67% | |
Selling, General and Administrative Expense of Revenue |
37.71% | 37.17% | 36.30% | 33.20% | |
Share Based Compensation of Revenue |
14.01% | 13.09% | 12.41% | 11.80% | |
Operating CF/Net income |
0.98 | 1.11 | 1.13 | 1.44 | |
Depreciation/Fixed assets |
0.04 | 0.04 | 0.04 | 0.04 | |
Capex/Depreciation |
(1.76) | (1.94) | (2.18) | (2.05) | |
Revenue per Share |
13.44 | 14.25 | 14.92 | 15.87 | |
Operating CF per Share |
6.94 | 8.55 | 9.22 | 10.94 | |
Capex per Share |
(0.40) | (0.44) | (0.49) | (0.47) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026